Repare Therapeutics Inc (RPTX)
NASDAQ:RPTX
US Market
Holding RPTX?
Track your performance easily

Repare Therapeutics (RPTX) Financial Statements

359 Followers

Repare Therapeutics Financial Overview

Repare Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.633; its P/E ratio is -2.13; Repare Therapeutics is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.87. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-$ 52.40M$ -32.41M--
Gross Profit-----
EBIT$ -34.45M$ 10.82M$ -30.87M$ -35.18M$ -8.84M
EBITDA$ -31.58M$ 11.32M$ -30.36M$ -36.56M$ -10.42M
Net Income Common Stockholders$ -34.77M$ 13.16M$ -28.03M$ -18.88M$ -11.95M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 208.12M$ 237.00M$ 223.63M$ 250.07M$ 280.69M
Total Assets$ 235.34M$ 263.08M$ 253.90M$ 286.41M$ 301.59M
Total Debt$ 2.17M$ 2.78M$ 3.41M$ 3.92M$ 4.55M
Net Debt$ -205.95M$ -234.22M$ -220.22M$ -246.15M$ -276.15M
Total Liabilities$ 31.67M$ 31.13M$ 41.82M$ 53.04M$ 56.17M
Stockholders Equity$ 203.68M$ 231.95M$ 212.08M$ 233.37M$ 245.41M
Cash Flow-
Free Cash Flow$ -30.51M$ 11.93M$ -28.55M$ -32.87M$ -35.41M
Operating Cash Flow$ -30.51M$ 11.93M$ -28.16M$ -32.87M$ -34.35M
Investing Cash Flow$ 7.12M$ -20.32M$ 31.88M$ 24.50M$ 28.35M
Financing Cash Flow-$ 375.00K$ 105.00K$ 284.00K$ 40.00K
Currency in USD

Repare Therapeutics Earnings and Revenue History

Repare Therapeutics Debt to Assets

Repare Therapeutics Cash Flow

Repare Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis